Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
1.010
+0.010 (1.00%)
At close: Nov 21, 2024, 4:00 PM
1.030
+0.020 (1.98%)
After-hours: Nov 21, 2024, 5:01 PM EST
Nektar Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -168.3 | -276.06 | -368.2 | -523.84 | -444.44 | -440.67 | Upgrade
|
| Depreciation & Amortization | 5.71 | 7.82 | 13.03 | 14.15 | 14.18 | 13.16 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.3 | 1.3 | -3.33 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 7.03 | 111.83 | 70.71 | 16.7 | - | - | Upgrade
|
| Stock-Based Compensation | 24.06 | 33.39 | 57.32 | 94.67 | 94.26 | 99.8 | Upgrade
|
| Other Operating Activities | -46.92 | -51.08 | -74.04 | 8.63 | 5.96 | -22.65 | Upgrade
|
| Change in Accounts Receivable | 0.16 | 4.78 | 16.51 | 12.4 | 1.91 | 6.41 | Upgrade
|
| Change in Inventory | 0.26 | 0.7 | -3.4 | -0.51 | -2.63 | -1.28 | Upgrade
|
| Change in Accounts Payable | 5.42 | -2.88 | 3.1 | -11.69 | 2.38 | 12.97 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -5.52 | -16.57 | Upgrade
|
| Change in Other Net Operating Assets | -5.3 | -22.39 | -15.72 | -23.17 | 20.6 | 20.16 | Upgrade
|
| Operating Cash Flow | -176.57 | -192.61 | -304.01 | -412.66 | -313.29 | -328.68 | Upgrade
|
| Capital Expenditures | -1.25 | -0.87 | -5.68 | -14.99 | -7.26 | -26.29 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.25 | 13.2 | - | - | - | Upgrade
|
| Investment in Securities | 100.99 | 139.18 | 358.32 | 217.77 | 503.47 | 233.17 | Upgrade
|
| Investing Cash Flow | 99.74 | 139.56 | 365.84 | 202.78 | 496.21 | 206.89 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -250 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -250 | - | Upgrade
|
| Issuance of Common Stock | 0.05 | 0.03 | 0.76 | 33.24 | 23.4 | 23.36 | Upgrade
|
| Other Financing Activities | 45 | - | 0.75 | 3 | 146.25 | - | Upgrade
|
| Financing Cash Flow | 42.05 | 0.03 | 1.51 | 36.24 | -80.35 | 23.36 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | 0.06 | -0.33 | -0.09 | 0.02 | -0.1 | Upgrade
|
| Net Cash Flow | -34.81 | -52.95 | 63.01 | -173.74 | 102.59 | -98.54 | Upgrade
|
| Free Cash Flow | -177.82 | -193.47 | -309.68 | -427.65 | -320.55 | -354.97 | Upgrade
|
| Free Cash Flow Margin | -190.92% | -214.68% | -336.41% | -419.65% | -209.62% | -309.70% | Upgrade
|
| Free Cash Flow Per Share | -0.88 | -1.02 | -1.65 | -2.33 | -1.79 | -2.03 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 9.74 | 19.2 | Upgrade
|
| Cash Income Tax Paid | - | 2.66 | 0.27 | 0.33 | 0.54 | 0.56 | Upgrade
|
| Levered Free Cash Flow | -74.48 | -63.63 | -101.13 | -234.18 | -125.51 | -205.19 | Upgrade
|
| Unlevered Free Cash Flow | -58.96 | -47.8 | -83.06 | -204.61 | -102.31 | -176.22 | Upgrade
|
| Change in Net Working Capital | 2.56 | 3.62 | -2.41 | 19.62 | -33.96 | -12.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.